Skip to main content

Table 2 Patient characteristics after propensity score matching

From: Comparison of operative outcomes between monopolar and bipolar coagulation in hepatectomy: a propensity score-matched analysis in a single center

 

Monopolar (n = 73)

Bipolar (n = 73)

P value

Age

70 (31–87, 13)

69 (38–85, 16)

0.994

Sex (male/female)

52/21

51/22

0.856

BMI

22.2 (15.4–32.2, 4.20)

22.8 (15.9–37.1, 4.50)

0.768

ASA (1/2/3)

5/56/12

9/54/10

0.506

Diagnosis (HCC/CCC/meta/biliary tract cancer/benign disease/other)

41/7/15/2/8/0

46/4/15/3/5/0

0.246

Background liver disease (normal/HCV/HBV/ASH/NASH/other)

35/22/6/3/4/3

30/28/8/2/3/2

0.475

Liver fibrosisa (f0–1, f2–4)

29/33

23/38

0.309

Type of resection (partial/lateral/subsegmentectomy/segmentectomy/hemihepatectectomy/trisegmentectomy)

17/1/25/10/20/0

18/1/25/10/19/0

0.433

Number of resected lesions

1 (1–16, 0)

1 (1–3, 0)

0.365

Size of the largest nodule on preoperative imagingb (cm)

2.7 (0.9–20, 3.0)

2.4 (0.5–10, 1.9)

0.147

Number of nodules on preoperative imagingb

1 (1–10, 0)

1 (1–10, 1)

0.513

Lymph node dissection (yes/no)

11/62

9/64

0.630

Biliary reconstruction (yes/no)

5/68

6/67

0.754

Intraoperative drain insert (yes/no)

73/0

72/1

0.500

Duration of drain placement

4 (0–131, 4)

5 (2–94, 3)

0.112

Neoadjuvant chemotherapy (yes/no/previous)

10/62/1

11/60/2

0.584

Total bilirubin (mg/dL) (≥ 1.1/ < 1.1)

16/57

17/56

0.843

Aspartate transaminase (IU/L) (≥ 31/ < 31)

36/37

38/35

0.741

Albumin (g/dL) (≥ 3.9/ < 3.9)

26/47

26/47

1.000

Prothrombin activity (%) (≥ 69/ < 69)

69/4

71/2

0.340

Activated partial thromboplastin time (%) (≥ 69/ < 69)

62/11

65/8

0.461

Hemoglobin (g/dL) (≥ 11.4/ < 11.4)

58/15

59/14

0.836

Platelet (× 104/μL) (≥ 15.3/ < 15.3)

45/28

43/30

0.735

Blood urea nitrogen (mg/dL) (≥ 20.0/ < 20.0)

11/62

10/63

0.814

Creatinine (mg/dL) (≥ 1.07/ < 1.07)

14/59

9/64

0.256

C-reactive proteinc (mg/dL) (≥ 0.14/ < 0.14)

28/43

22/35

0.923

ICGR15d (%) (≥ 10/ < 10)

45/25

45/25

0.557

Child–Pugh score

5 (5–6, 0)

5 (5–8, 0)

0.084

  1. Continuous data are presented as median (range, interquartile range), whereas categorical data are shown as number of patients
  2. BMI, body mass index; ASA, American Society of Anesthesiologists; HCC, hepatocellular carcinoma; CCC, cholangiocellular carcinoma; meta, liver metastasis; HCV, hepatitis C virus; HBV, hepatitis B virus; ASH, alcoholic steatohepatitis; NASH, non-alcoholic steatohepatitis; ICGR15, indocyanine green retention rate at 15 min
  3. aData on liver fibrosis were partially lacking (monopolar, 62 cases; bipolar, 61 cases)
  4. bData on the size of the largest nodule and number of nodules were partially lacking because biliary tract cancer and benign disease could not be accurately measured (monopolar, 66 cases; bipolar, 68 cases)
  5. cData on C-reactive protein were partially lacking (monopolar, 71 cases; bipolar, 57 cases)
  6. dData on ICGR15 were partially lacking (monopolar, 70 cases; bipolar, 70 cases)